Mammea A/BA
Product Specifications
CAS Number
5224-54-4
Target
Others, Autophagy, Parasite, Reactive Oxygen Species, Apoptosis
Related Pathways
Others, NF-κB, Metabolism, Immunology/Inflammation, Apoptosis, Autophagy, Microbiology/Virology
Bioactivity
Mammea A/BA demonstrates significant efficacy in inhibiting Trypanosoma cruzi (T. cruzi), through mechanisms such as mitochondrial dysfunction, increased production of reactive oxygen species (ROS), and DNA fragmentation, alongside elevating acidic vacuole numbers. This compound is capable of inducing apoptosis, autophagy, and necrosis, making it a valuable research tool for Chagas disease.
Smiles
OC1=C2C(=C(C(CC(C)C)=O)C(O)=C1CC=C(C)C)OC(=O)C=C2C3=CC=CC=C3
Molecular Formula
C25H26O5
Molecular Weight
406.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15120876 1 Vial
Lentiviral human ALDH1L2 shRNA (UAS) - Lentiviral human ALDH1L2 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
123866-ML490 100 µL
BCAR1 (CAS, CASS1, CRKAS, Breast Cancer Anti-estrogen Resistance Protein 1, CRK-associated Substrate, Cas Scaffolding Protein Family Member 1, p130cas) (MaxLight 490)
Sign In for Pricing
View Details MBS2110161-01 0.1 mL
HRP-Linked Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Sign In for Pricing
View Details MBS2110161-02 0.2 mL
HRP-Linked Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Sign In for Pricing
View Details MBS2110161-03 0.5 mL
HRP-Linked Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
Sign In for Pricing
View Details